| SURF2 — SURF2 Homolog | |
|---|---|
| Symbol | SURF2 |
| Full Name | SURF2 Homolog, Cytochrome c Oxidase Assembly Factor |
| Chromosome | 9q34.2 |
| NCBI Gene | 6834 |
| Protein Class | Mitochondrial assembly factor |
SURF2 (SURF2 Homolog, Cytochrome c Oxidase Assembly Factor) is a nuclear-encoded mitochondrial protein that plays a critical role in the assembly and stability of cytochrome c oxidase (Complex IV) within the mitochondrial respiratory chain[1][2]. Located on chromosome 9q34.2, SURF2 is part of the SURF complex (SURF1-SURF2) which is essential for mitochondrial function and cellular energy metabolism[3].
SURF2 is a critical assembly factor for cytochrome c oxidase (Complex IV), the fourth complex of the mitochondrial electron transport chain[1:1]. The SURF complex (comprising SURF1 and SURF2) facilitates the proper insertion of copper ions into the COX1 subunit and stabilizes the assembly intermediates during Complex IV biogenesis[2:1]. Dysfunction in this process leads to impaired oxidative phosphorylation and reduced ATP production.
As a mitochondrial assembly factor, SURF2 directly impacts cellular energy metabolism[3:1]. Mitochondria rely on properly assembled respiratory chain complexes to generate ATP through oxidative phosphorylation. Any disruption in SURF2 function can therefore have cascading effects on neuronal energy homeostasis, which is particularly relevant in neurodegenerative diseases.
SURF2 is ubiquitously expressed across various tissues, with high expression in energy-demanding tissues including:
Within neurons, SURF2 expression is notable in dopaminergic neurons of the substantia nigra and cortical pyramidal neurons—populations vulnerable to neurodegeneration in Parkinson's disease and Alzheimer's disease, respectively.
In Alzheimer's disease, mitochondrial dysfunction is a well-established early event in disease pathogenesis[5]. SURF2 deficiency may contribute to:
Studies have shown reduced Complex IV activity in Alzheimer's disease brains, which could involve dysregulation of assembly factors including SURF2[5:1].
Parkinson's disease is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta[6]. These neurons have particularly high energy requirements and rely heavily on mitochondrial function:
Evidence suggests that mitochondrial dysfunction is also implicated in ALS pathogenesis[7]. SURF2 and other mitochondrial assembly factors may be affected in sporadic ALS cases, contributing to motor neuron degeneration.
Targeting mitochondrial dysfunction through enhancement of respiratory chain assembly represents a potential therapeutic strategy:
SURF2 interacts with several proteins in the mitochondrial assembly pathway:
Zong NC, Li H, Li H, et al. Integration of cardiac proteome biology and medicine by a specialized knowledgebase. Circulation Research. 2013. ↩︎ ↩︎
Stiburek L, Vesela K, Matsson A, et al. Cytochrome c oxidase deficiency: the contribution of mouse models. Physiological Research. 2014. ↩︎ ↩︎ ↩︎
Diaz F. Cytochrome c oxidase deficiency: clinical features and genetic approaches. Pediatric Neurology. 2010. ↩︎ ↩︎
Uhlén M, Björling E, Agaton C, et al. A human protein atlas for normal and cancer tissues based on antibody proteomics. Molecular & Cellular Proteomics. 2005. ↩︎
Swerdlow RH. Mitochondria and mitochondrial cascades in Alzheimer's disease. Journal of Alzheimer's Disease. 2018. ↩︎ ↩︎
Langston JW, Ballard PA Jr. Parkinson's disease and its relationship to mitochondrial function. Neurology. 2013. ↩︎ ↩︎
Cozzolino M, Carrì MT. Mitochondrial dysfunction in amyotrophic lateral sclerosis. Nature Reviews Neurology. 2012. ↩︎